Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 295 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| MAN2B1 | ENSG00000104774 | 0.00 | 0.00 | 0 | 0 |
| HTR2A | ENSG00000102468 | 0.00 | 0.00 | 0 | 0 |
| CLCN3 | ENSG00000109572 | 0.00 | 0.00 | 0 | 0 |
| SLC25A14 | ENSG00000102078 | 0.00 | 0.00 | 0 | 0 |
| GABRB1 | ENSG00000163288 | 0.00 | 0.00 | 0 | 0 |
| TAF15 | ENSG00000270647 | 0.00 | 0.00 | 0 | 0 |
| ACVR1B | ENSG00000135503 | 0.00 | 0.00 | 0 | 0 |
| SOAT2 | ENSG00000167780 | 0.00 | 0.00 | 0 | 0 |
| KHDRBS1 | ENSG00000121774 | 0.00 | 0.00 | 0 | 0 |
| PEPD | ENSG00000124299 | 0.00 | 0.00 | 0 | 0 |
| IGF1 | ENSG00000017427 | 0.00 | 0.00 | 0 | 0 |
| ATP1A4 | ENSG00000132681 | 0.00 | 0.00 | 0 | 0 |
| HSD17B3 | ENSG00000130948 | 0.00 | 0.00 | 0 | 0 |
| NLK | ENSG00000087095 | 0.00 | 0.00 | 0 | 0 |
| GABRR2 | ENSG00000111886 | 0.00 | 0.00 | 0 | 0 |
| MAN2B2 | ENSG00000013288 | 0.00 | 0.00 | 0 | 0 |
| GRIN2A | ENSG00000183454 | 0.00 | 0.00 | 0 | 0 |
| PLCZ1 | ENSG00000139151 | 0.00 | 0.00 | 0 | 0 |
| ATP2B1 | ENSG00000070961 | 0.00 | 0.00 | 0 | 0 |
| REG3G | ENSG00000143954 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 295 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.